latest news releases from the newsroom
NASDAQ to Offer Convertible Notes
NEW YORK, Feb. 20, 2008 (PRIME NEWSWIRE) -- The Nasdaq Stock Market, Inc. (Nasdaq:NDAQ) today announced that it is planning to offer $425 million aggregate principal amount of convertible senior notes due 2013, subject to market and other customary conditions. Upon conversion, holders will receive, at the election of NASDAQ, cash, common stock or a combination of cash and common stock. NASDAQ may sell up to an additional aggregate $50 million of notes upon exercise of an over-allotment option that NASDAQ expects to grant to the initial purchasers in connection with the offering. NASDAQ intends to use the net proceeds from this offering, available cash and borrowings under a new senior secured credit facility to fund its combination with OMX AB (publ) (OMX), investment in the Dubai International Financial Exchange and proposed acquisitions of The Philadelphia Stock Exchange, Inc. (PHLX) and the Boston Stock Exchange, as well as to repay certain indebtedness of OMX and PHLX, provide ongoing working capital and provide for other general corporate purposes.
FCI USA, Inc.
Photo Release -- FCI Introduces Revolutionary New ErgoMate Technology On the Apex 24-Way Hybrid Connector
NOVI, Mich., Feb. 20, 2008 (PRIME NEWSWIRE) -- FCI USA, Inc., a leading supplier of electrical connectors to the OEM automotive industry, introduces the ErgoMate(tm) Axial Mate Assist System now available on the new USCAR compliant APEX(r) 24-circuit hybrid connector. ErgoMate is a new way to mate larger connectors that improves reliability and ergonomics, shrinks packaging space and reduces connection time, announced Ed de Chazal, FCI North America marketing manager.
MEDTOX Scientific, Inc.
MEDTOX Scientific Announces Strong Results for Fourth Quarter and Year-End
ST. PAUL, Minn., Feb. 20, 2008 (PRIME NEWSWIRE) -- MEDTOX Scientific, Inc. (Nasdaq:MTOX) today announced fourth quarter and year-end results for the periods ending December 31, 2007. For the year ended December 31, 2007, MEDTOX achieved record revenues, gross profit, gross margin and operating income: